- Report
- July 2023
- 210 Pages
Global
From €1921EUR$1,990USD£1,648GBP
- Report
- April 2024
- 334 Pages
Global
From €5405EUR$5,600USD£4,637GBP
- Report
- January 2024
- 148 Pages
Global
From €3763EUR$3,899USD£3,228GBP
- Report
- January 2024
- 139 Pages
Global
From €3763EUR$3,899USD£3,228GBP
- Report
- January 2024
- 199 Pages
Global
From €3507EUR$3,633USD£3,008GBP
€5009EUR$5,190USD£4,297GBP
- Report
- November 2023
- 150 Pages
Global
From €3074EUR$3,185USD£2,637GBP
€4392EUR$4,550USD£3,767GBP
- Report
- February 2024
- 117 Pages
Global
From €4585EUR$4,750USD£3,933GBP
- Report
- February 2024
- 115 Pages
Global
From €4585EUR$4,750USD£3,933GBP
- Report
- February 2024
- 187 Pages
Global
From €4585EUR$4,750USD£3,933GBP
- Report
- February 2024
- 120 Pages
Global
From €4585EUR$4,750USD£3,933GBP
- Report
- February 2024
- 159 Pages
Global
From €4585EUR$4,750USD£3,933GBP
- Report
- November 2023
- 30 Pages
Global
From €2654EUR$2,750USD£2,277GBP
- Report
- November 2023
- 30 Pages
Global
From €3137EUR$3,250USD£2,691GBP
- Report
- November 2023
- 30 Pages
Global
From €2654EUR$2,750USD£2,277GBP
- Report
- November 2023
- 30 Pages
Global
From €2654EUR$2,750USD£2,277GBP
- Report
- November 2023
- 30 Pages
Global
From €2654EUR$2,750USD£2,277GBP
- Report
- November 2023
- 30 Pages
Global
From €2654EUR$2,750USD£2,277GBP
- Report
- November 2023
- 30 Pages
Global
From €2654EUR$2,750USD£2,277GBP
- Report
- February 2024
- 185 Pages
Global
From €4729EUR$4,900USD£4,057GBP
- Report
- November 2023
- 190 Pages
Global
From €4729EUR$4,900USD£4,057GBP
The Flu Vaccine market is a subset of the larger Vaccines market, which is composed of products designed to prevent and treat infectious diseases. Flu Vaccines are specifically designed to protect against influenza, a highly contagious virus that can cause severe illness and even death. Flu Vaccines are typically administered annually, and are recommended for people of all ages, including pregnant women and those with chronic health conditions.
Flu Vaccines are typically developed by pharmaceutical companies, and are then approved and distributed by government health agencies. In addition to traditional flu vaccines, there are also recombinant vaccines, which are produced using genetic engineering techniques.
Companies in the Flu Vaccine market include Sanofi Pasteur, GlaxoSmithKline, Merck & Co., Pfizer, and Novartis. Show Less Read more